Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can cataract be prevented?

J J Harding1

  • 1Nuffield Laboratory of Ophthalmology, University of Oxford, UK.

Eye (London, England)
|January 11, 2000
PubMed
Summary
This summary is machine-generated.

Preventing cataracts through risk factor elimination is challenging globally. However, non-steroidal anti-inflammatory drugs show promise in preventing cataracts, warranting further clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers.

Investigational new drugs·2021
Same author

Characterization of on-target adverse events caused by TRK inhibitor therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Comments on the role of metal-catalysed autoxidation in glycation and the Maillard reaction.

Redox report : communications in free radical research·2016
Same author

Investigation of gammaE-crystallin target protein binding to bovine lens alpha-crystallin by small-angle neutron scattering.

Biochimica et biophysica acta·2009
Same author

Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.

Molecular vision·2008
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
Same journal

Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.

Eye (London, England)·2026
Same journal

Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

Eye (London, England)·2026
Same journal

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

Eye (London, England)·2026
Same journal

"When the lens drew a continent: a cartographic clue to Alport syndrome".

Eye (London, England)·2026
Same journal

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Preventive Medicine

Background:

  • Cataract prevention strategies include risk factor elimination and anti-cataract therapies.
  • Major risk factor elimination presents challenges, particularly in Western countries, but holds potential in developing nations.
  • Past drug therapy approaches, including aldose reductase inhibitors, faced significant hurdles like toxicity and invalidated hypotheses.

Purpose of the Study:

  • To review the feasibility of cataract prevention via risk factor modification and anti-cataract drug therapy.
  • To assess the efficacy and challenges associated with various anti-cataract therapeutic approaches.
  • To highlight promising new avenues for cataract prevention, including non-steroidal anti-inflammatory drugs.

Main Methods:

Related Experiment Videos

  • Review of existing literature on cataract prevention strategies.
  • Analysis of the development and outcomes of aldose reductase inhibitors.
  • Examination of in vitro, animal model, and human association studies for non-steroidal anti-inflammatory drugs.

    • Main Results:

    • Eliminating major cataract risk factors is difficult in Western countries but feasible in developing regions.
    • Aldose reductase inhibitors faced toxicity issues and their initial hypothesis was disproven.
    • Non-steroidal anti-inflammatory drugs (aspirin, paracetamol, ibuprofen) demonstrated positive in vitro results, prevented diabetic cataract in rats, and showed a protective association in human patients.

    Conclusions:

    • While risk factor elimination has limitations, drug therapies offer potential for cataract prevention.
    • Non-steroidal anti-inflammatory drugs show significant promise and require further investigation through clinical trials.
    • Continued research into novel anti-cataract agents is essential for advancing prevention strategies.